- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02977377
The Effects Of Whole Body Vibration On Postural Control In Patients With Ataxia
Ataksili Hastalarda Tüm Vücut Vibrasyonunun Postüral Kontrol Üzerine Etkileri
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients will be randomly assigned to 2 groups, group 1 will take only exercise therapy, group 2 will take exercise therapy and whole body vibration together. After 1 week wash-out period, patients assigned other therapy period. All assessments will be repeated before and after each therapy period. Exercise therapy will consist of selected balance, coordination and walking exercises according to the individual needs of patients. Whole body vibration (20-30 Hz, minimum amplitude) will be applied to cases in the form of 4 sets (1 min application and 1min rest.) Cases will take the treatment 1-hour, 3 days in a week for 8 weeks.
The evaluation parameters consists of demographic information, Computerized Dynamic Posturography, International Cooperative Ataxia Rating Scale, Trunk Impairment Scale, Berg Balance Scale, Barthel Index and Goal Assessment Scale.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey, 06100
- Hacettepe University, Faculty of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clinical diagnosis of ataxia
- Ataxic patients who are able to walk 25 m independently
Exclusion Criteria:
- Clinical diagnosis of systemic problems (Diabetes Mellitus, Hypertension)
- Clinical diagnosis of cognitive impairment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Whole body vibration/ Exercise
Exercise therapy and whole body vibration will be applied together for 8 weeks.
Selected balance, coordination and walking exercises according to the individual needs of patients.
Whole body vibration (20-30 Hz, minimum amplitude) will be applied to cases in the form of 4 sets (1 min application and 1min rest) before exercises.
After 1 week washout period, exercise program will apply for 8 weeks.
|
Cases will take the treatment 1-hour, 3 days in a week for 8 weeks.
4 sets, 1 min application and 1min rest whole body vibration and after that exercises.
Cases will take the treatment 1-hour, 3 days in a week for 8 weeks.
|
Active Comparator: Exercise/ Whole body vibration
Exercise therapy will be applied for 8 weeks.
Selected balance, coordination and walking exercises according to the individual needs of patients.
After 1 week washout period exercise therapy and whole body vibration will be applied together for 8 weeks.
|
Cases will take the treatment 1-hour, 3 days in a week for 8 weeks.
4 sets, 1 min application and 1min rest whole body vibration and after that exercises.
Cases will take the treatment 1-hour, 3 days in a week for 8 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensory organization test of Computerized Dynamic Posturography (CDP)
Time Frame: change from baseline in sensory component of postural control at 8 weeks
|
Computerized Dynamic Posturography (CDP) is a unique assessment technique used to objectively quantify and differentiate among the wide variety of possible sensory, motor, and central adaptive impairments to balance control.
CDP has severeal test protocols; a Sensory Organization Test (SOT), Limits of Stability Test (LOS), a Motor Control Test (MCT) and an Adaptation Test (ADT) used in the study.
Sensory organization test (SOT) evaluates the relative contributions of vestibular, visual and somatosensory systems to balance maintenance when somatosensory information regarding the orientation of the body's centre of gravity is systematically manipulated.
|
change from baseline in sensory component of postural control at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Cooperative Ataxia Rating Scale
Time Frame: change from baseline in severity of ataxic symptoms at 8 weeks.
|
The ICARS was developed to quantify the level of impairment as a result of ataxia as related to hereditary ataxias.
Disorders rated as subscales within the ICARS are: Postural and gait disturbances, Limb Ataxia, Dysarthria and Oculomotor disorders.
|
change from baseline in severity of ataxic symptoms at 8 weeks.
|
Trunk Impairment Scale
Time Frame: change from baseline in impairment of trunk at 8 weeks.
|
To measure the motor impairment of the trunk through the evaluation of static and dynamic sitting balance as well as co-ordination of trunk movement.
Three subscales: static sitting, balance, dynamic sitting balance and coordination.
Each subscale has between three and 10 items.
|
change from baseline in impairment of trunk at 8 weeks.
|
Berg Balance Scale
Time Frame: change from baseline in balance performance at 8 weeks.
|
A 14-item objective measure designed to assess static balance and fall risk.
Static and dynamic activities of varying difficulty are performed.Item-level scores range from 0-4, determined by ability to perform the assessed activity.
Item scores are summed.Maximum score is 56.
|
change from baseline in balance performance at 8 weeks.
|
Barthel Index
Time Frame: change from baseline in performance of activitiesof daily living (ADL) at 8 weeks.
|
The Barthel includes 10 personal activities.
Clinically, the Barthel can be administered via interview, by observation of the patient's performance in a specific setting, or by asking the patient to demonstrate an activity.The response categories of disability in an activity were defined and rated in scale steps (0, 5), (0, 5, 10), (0, 5, 10, 15) dependent on the item.
For example, for performance of dressing activity, 0 means dependent, 5 means patient needs help but can do about half unaided, 10 means independent (including buttons, zips, laces, etc.)
An overall score is formed by adding scores on each rating.
Scores range from 0 (totally dependent) to 100 (fully independent), in steps of 5, with higher scores indicating greater independence.
|
change from baseline in performance of activitiesof daily living (ADL) at 8 weeks.
|
Goal Assessment Scale
Time Frame: change from baseline in satisfaction regarding how to reach the goals related therapy at 8 weeks.
|
The Goal Attainment Scale (GAS) is an individualized outcome measure involving goal selection and goal scaling that is standardized in order to calculated the extent to which a patient's goals are met.
Each patient effectively has their own outcome measure, but these measures are scored in a standardized way.
"Successful" outcomes are agreed upon prior to intervention.
Scoring: Each goal is rated on a 5-point scale.
0 = Patient achieves the expected level; +1 = somewhat more than expected; +2 = much more than expected; -1 = somewhat less than expected; -2 = much less than expected.
Overall score is calculated by incorporating the goal outcome scores into a single aggregated T-score.
(Optional): Goals may be weighted by the patient for importance or difficulty.
|
change from baseline in satisfaction regarding how to reach the goals related therapy at 8 weeks.
|
Limits of stability test of Computerized Dynamic Posturography (CDP)
Time Frame: change from baseline in dynamic balance component of postural control at 8 weeks
|
Limits of stability test (LOS) assesses dynamic balance during the performance of specific tasks with visual feedback.
It quantifies objectively the maximum distance a person can lean in a given direction without losing balance, stepping or reaching for assistance.
|
change from baseline in dynamic balance component of postural control at 8 weeks
|
Motor Control Test of Computerized Dynamic Posturography (CDP)
Time Frame: change from baseline in automatic motor system component of postural control at 8 weeks
|
Motor Control Test (MCT) assesses the ability of the automatic motor system to quickly recover following an unexpected external disturbance.
Sequences of platform translations of varied sizes in forward and backward directions elicit automatic postural responses.
The size of the translation is scaled to the patient's height to produce sway disturbances of equal size.
|
change from baseline in automatic motor system component of postural control at 8 weeks
|
Adaptation Test of Computerized Dynamic Posturography (CDP)
Time Frame: change from baseline in postural sway in changes of support surface component of postural control at 8 weeks
|
Adaptation Test (ADT) assesses the patient's ability to minimize sway when exposed to irregularities and unexpected changes in support surface properties.
Sequences of platform rotations in the toes-up or toes-down direction elicit automatic motor responses.
|
change from baseline in postural sway in changes of support surface component of postural control at 8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ender Ayvat, Msc, Hacettepe University
- Principal Investigator: Muhammed Kılınç, Assoc Prof, Hacettepe University
- Study Director: Sibel Aksu, Prof, Hacettepe University
Publications and helpful links
General Publications
- Krasny-Pacini A, Hiebel J, Pauly F, Godon S, Chevignard M. Goal attainment scaling in rehabilitation: a literature-based update. Ann Phys Rehabil Med. 2013 Apr;56(3):212-30. doi: 10.1016/j.rehab.2013.02.002. Epub 2013 Feb 28.
- Yelnik A, Bonan I. Clinical tools for assessing balance disorders. Neurophysiol Clin. 2008 Dec;38(6):439-45. doi: 10.1016/j.neucli.2008.09.008. Epub 2008 Oct 18.
- Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997 Feb 12;145(2):205-11. doi: 10.1016/s0022-510x(96)00231-6.
- Verheyden G, Nieuwboer A, Mertin J, Preger R, Kiekens C, De Weerdt W. The Trunk Impairment Scale: a new tool to measure motor impairment of the trunk after stroke. Clin Rehabil. 2004 May;18(3):326-34. doi: 10.1191/0269215504cr733oa.
- Berg KO, Maki BE, Williams JI, Holliday PJ, Wood-Dauphinee SL. Clinical and laboratory measures of postural balance in an elderly population. Arch Phys Med Rehabil. 1992 Nov;73(11):1073-80.
- Ebersbach G, Edler D, Kaufhold O, Wissel J. Whole body vibration versus conventional physiotherapy to improve balance and gait in Parkinson's disease. Arch Phys Med Rehabil. 2008 Mar;89(3):399-403. doi: 10.1016/j.apmr.2007.09.031.
- van Nes IJ, Latour H, Schils F, Meijer R, van Kuijk A, Geurts AC. Long-term effects of 6-week whole-body vibration on balance recovery and activities of daily living in the postacute phase of stroke: a randomized, controlled trial. Stroke. 2006 Sep;37(9):2331-5. doi: 10.1161/01.STR.0000236494.62957.f3. Epub 2006 Aug 10.
- Roll JP, Vedel JP, Ribot E. Alteration of proprioceptive messages induced by tendon vibration in man: a microneurographic study. Exp Brain Res. 1989;76(1):213-22. doi: 10.1007/BF00253639.
- Torvinen S, Kannus P, Sievanen H, Jarvinen TA, Pasanen M, Kontulainen S, Jarvinen TL, Jarvinen M, Oja P, Vuori I. Effect of four-month vertical whole body vibration on performance and balance. Med Sci Sports Exerc. 2002 Sep;34(9):1523-8. doi: 10.1097/00005768-200209000-00020.
- Bruyere O, Wuidart MA, Di Palma E, Gourlay M, Ethgen O, Richy F, Reginster JY. Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residents. Arch Phys Med Rehabil. 2005 Feb;86(2):303-7. doi: 10.1016/j.apmr.2004.05.019.
- Ayvat E, Kilinc M, Ayvat F, Onursal Kilinc O, Aksu Yildirim S. The Effect of Whole Body Vibration on Postural Control of Ataxic Patients: a Randomized Controlled Cross-Over Study. Cerebellum. 2021 Aug;20(4):533-541. doi: 10.1007/s12311-021-01233-y. Epub 2021 Jan 21.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GO 14/397
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ataxia
-
Cadent TherapeuticsWithdrawnSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8 | Spinocerebellar Ataxia Type 17 | ARCA1 - Autosomal Recessive...United States
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8United States, China
-
Assistance Publique - Hôpitaux de ParisCompletedSpinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia, Autosomal Recessive 3 | Episodic Ataxia, Type 7France
-
University of ChicagoPfizer; Biogen; APDM Wearable TechnologiesActive, not recruitingSpinocerebellar Ataxia Type 3 | Friedreich Ataxia | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6United States
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingSpinocerebellar Ataxias | Spinocerebellar Ataxia Genotype Type 1 | Spinocerebellar Ataxia Genotype Type 2 | Spinocerebellar Ataxia Genotype Type 3 | Spinocerebellar Ataxia Genotype Type 6 | Spinocerebellar Ataxia Genotype Type 7 | Spinocerebellar Ataxia Genotype Type 8 | Spinocerebellar Ataxia Genotype...United States
-
University of California, Los AngelesRare Diseases Clinical Research Network; Office of Rare Diseases (ORD)CompletedCerebellar Diseases | Episodic Ataxia SyndromeUnited States, Canada, United Kingdom
-
Teachers College, Columbia UniversityActive, not recruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 7United States
-
Sclnow Biotechnology Co., Ltd.Not yet recruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6
-
University of California, Los AngelesActive, not recruitingSpinocerebellar Ataxias | Spinocerebellar Ataxia 3 | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | MSA-CUnited States
-
Seoul National University HospitalCompletedAtaxia, Cerebellar | Ataxia, ProgressiveKorea, Republic of
Clinical Trials on Exercise therapy
-
University Hospital, GhentActive, not recruitingInsertional Achilles TendinopathyBelgium
-
Norwegian University of Science and TechnologyCompletedPatellofemoral Pain Syndrome
-
Proaxis TherapyVirginia Commonwealth University; Arcadia University; National Athletic Trainers...CompletedShoulder Impingement SyndromeUnited States
-
Istanbul Physical Medicine Rehabilitation Training...Completedthe Effect of Virtual Reality on Stroke Rehabilitation
-
Taipei Medical UniversityNot yet recruiting
-
Royal College of Surgeons, IrelandUnknownHip OsteoarthritisIreland
-
George Washington UniversityCompletedPrematurityUnited States
-
University Hospital, GhentCompletedAchilles TendinopathyBelgium
-
Gazi UniversityCompletedTemporomandibular DisorderTurkey
-
University Hospital, GhentCompleted